First-in-human clinical trial for a vaccine to treat opioid use disorders enrolls first patients
The first patients have been enrolled in a phase 1 randomized placebo-controlled clinical trial to study a therapeutic vaccine for opioid use disorder developed by researchers at the University of Minnesota Medical School.
Sep 7, 2021
0
15
